The 12 Hallmarks of Aging in Dogs, Explained
Read full insightAntioxidants and Cancer in Dogs
Understand antioxidant nutrition, the actual canine studies, and the different decisions involved in healthy aging and cancer care.
As Seen On
Contents
References
Numbered references identify the sources used for specific claims. Read the study design, species and evidence boundaries alongside each finding.
-
American Animal Hospital Association. 2026 AAHA Oncology Guidelines: Section 7—Supportive and Symptomatic Care. Evidence boundary: Current oncology guidance on nutrition, comfort and supportive care; individualized to the patient.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4
-
Young A; UC Davis School of Veterinary Medicine. Nutritional Management of Patients with Cancer. Evidence boundary: Veterinary nutrition guidance on adequate intake, balanced food and feeding difficulties after a cancer diagnosis.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4
-
Raghavan M, Knapp DW, Bonney PL, Dawson MH, Glickman LT. Evaluation of the effect of dietary vegetable consumption on reducing risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. Evidence boundary: Case-control comparison of vegetable intake in Scottish Terriers with bladder cancer and other conditions; association rather than a feeding trial.↩ 1 · ↩ 2
-
Winter JL, Barber LG, Freeman L, Griessmayr PC, Milbury PE, Blumberg JB. Antioxidant status and biomarkers of oxidative stress in dogs with lymphoma. Evidence boundary: Observational comparison of antioxidant and oxidation measurements in 17 dogs with lymphoma and 10 healthy controls.↩
-
Heaton PR, Reed CF, Mann SJ, Ransley R, Stevenson J, Charlton CJ, Smith BH, Harper EJ, Rawlings JM. Role of dietary antioxidants to protect against DNA damage in adult dogs. Evidence boundary: Sixteen-week food trial in 40 adult dogs, including DNA-damage assays and vaccine-antibody measurements.↩ 1 · ↩ 2 · ↩ 3
-
Jewell DE, Motsinger LA, Paetau-Robinson I. Effect of dietary antioxidants on free radical damage in dogs and cats. Evidence boundary: Eighty-four-day complete-food trial with 40 healthy dogs and a separate cat cohort; cellular markers, not cancer outcomes. Industry funding disclosed.↩ 1 · ↩ 2 · ↩ 3 · ↩ 4
-
Waters DJ, Shen S, Cooley DM, Bostwick DG, Qian J, Combs GF, Glickman LT, Oteham C, Schlittler D, Morris JS. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. Evidence boundary: Seven-month selenium experiment in older male beagles measuring prostate-cell DNA damage and apoptosis, rather than cancer incidence.↩ 1 · ↩ 2
-
Zentrichová V, Pechová A, Kovaříková S. Selenium and Dogs: A Systematic Review. Evidence boundary: Systematic review of canine selenium nutrition, experimental toxicity and related research limitations.↩ 1 · ↩ 2
-
Ogilvie GK, Fettman MJ, Mallinckrodt CH, Walton JA, Hansen RA, Davenport DJ, Gross KL, Richardson KL, Rogers Q, Hand MS. Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study. Evidence boundary: Thirty-two-dog lymphoma diet trial alongside doxorubicin; the reported survival association depended on DHA and a disease-stage subgroup.↩
-
Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? Evidence boundary: Human clinical review of antioxidant supplementation during chemotherapy and radiation, with conflicting findings and treatment concerns.↩ 1 · ↩ 2
-
Gedney A et al. Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I’m-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma. Evidence boundary: Specific turkey-tail PSP study after splenectomy; adding PSP to doxorubicin did not improve survival. Supplier funding disclosed.↩
-
Fletcher RS et al. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. Evidence boundary: Mouse and cell research on NR metabolism with normal NAD-pathway context; not a canine oncology trial.↩
-
Reactome. Complex I oxidises NADH to NAD+, reduces CoQ to CoQH2. Evidence boundary: Curated normal mitochondrial reaction involving NADH and CoQ; human pathway annotation.↩
-
Reactome. glutathione (oxidized) + NADPH + H+ => 2 glutathione (reduced) + NADP+. Evidence boundary: Curated normal reaction using NADPH to regenerate reduced glutathione.↩ 1 · ↩ 2
-
Reactome. Vitamin B2 (riboflavin) metabolism. Evidence boundary: Curated riboflavin metabolism and FMN/FAD cofactor functions; normal biology.↩
-
National Center for Biotechnology Information. GPX1 glutathione peroxidase 1 [Homo sapiens (human)]. Evidence boundary: Official GPX1 functional summary describing glutathione-dependent peroxide handling; normal biochemistry.↩ 1 · ↩ 2
-
Forsythe LR, Gollakner R. Acetylcysteine. Evidence boundary: Veterinary acetylcysteine guidance on clinical use, adverse effects and interactions.↩
-
Hunter T, Williams K, Llera R, Ward E. Emergencies in Dogs. Evidence boundary: Veterinary guidance on urgent clinical signs and contacting emergency care.↩ 1 · ↩ 2
-
Sanderson SL. Nutritional Requirements of Small Animals. Evidence boundary: Professional nutrient guidance distinguishing vitamin A and its plant precursor beta-carotene in dogs.↩










